経カテーテル大動脈弁留置術(TAVI):医療機器パイプライン分析

◆英語タイトル:Transcatheter Aortic Valves Implantation (TAVI) - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0178
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:197
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Transcatheter Aortic Valves Implantation (TAVI) – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Transcatheter Aortic Valves Implantation (TAVI) – Medical Devices Pipeline Assessment, 2019″ provides an overview of Transcatheter Aortic Valves Implantation (TAVI) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transcatheter Aortic Valves Implantation (TAVI) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Transcatheter Aortic Valves Implantation (TAVI) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Transcatheter Aortic Valves Implantation (TAVI) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Transcatheter Aortic Valves Implantation (TAVI) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 6
1.2 List of Figures 12
2 Introduction 13
2.1 Transcatheter Aortic Valve Implantation (TAVI) Overview 13
3 Products under Development 14
3.1 Transcatheter Aortic Valve Implantation (TAVI) – Pipeline Products by Stage of Development 14
3.2 Transcatheter Aortic Valve Implantation (TAVI) – Pipeline Products by Territory 15
3.3 Transcatheter Aortic Valve Implantation (TAVI) – Pipeline Products by Regulatory Path 16
3.4 Transcatheter Aortic Valve Implantation (TAVI) – Pipeline Products by Estimated Approval Date 17
3.5 Transcatheter Aortic Valve Implantation (TAVI) – Ongoing Clinical Trials 18
4 Transcatheter Aortic Valve Implantation (TAVI) – Pipeline Products under Development by Companies 19
4.1 Transcatheter Aortic Valve Implantation (TAVI) Companies – Pipeline Products by Stage of Development 19
4.2 Transcatheter Aortic Valve Implantation (TAVI) – Pipeline Products by Stage of Development 21
5 Transcatheter Aortic Valve Implantation (TAVI) Companies and Product Overview 23
5.1 Admedus Ltd Company Overview 23
5.1.1 Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
5.2 Aegis Surgical Limited Company Overview 25
5.2.1 Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview 25
5.3 AorTx, Inc. Company Overview 26
5.3.1 AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.4 Arbor Surgical Technologies, Inc. Company Overview 27
5.4.1 Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.5 Boston Scientific Corp Company Overview 28
5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 28
5.6 Carena Healthcare Ltd Company Overview 54
5.6.1 Carena Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 54
5.7 Clemson University Company Overview 55
5.7.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 55
5.8 Colibri Heart Valve LLC Company Overview 56
5.8.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview 56
5.9 Daidalos Solutions BV Company Overview 62
5.9.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 62
5.10 Direct Flow Medical Inc (Inactive) Company Overview 63
5.10.1 Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 63
5.11 DSM Dyneema BV Company Overview 67
5.11.1 DSM Dyneema BV Pipeline Products & Ongoing Clinical Trials Overview 67
5.12 Dura LLC Company Overview 68
5.12.1 Dura LLC Pipeline Products & Ongoing Clinical Trials Overview 68
5.13 Edwards Lifesciences Corp Company Overview 69
5.13.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 69
5.14 Foldax Inc Company Overview 76
5.14.1 Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview 76
5.15 HLT, Inc. Company Overview 79
5.15.1 HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
5.16 JC Medical, Inc. Company Overview 83
5.16.1 JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
5.17 JenaValve Technology GmbH Company Overview 88
5.17.1 JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 88
5.18 Mayo Clinic Company Overview 91
5.18.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 91
5.19 Medtronic plc Company Overview 92
5.19.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 92
5.20 Meril Life Sciences Pvt Ltd Company Overview 95
5.20.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 95
6 Transcatheter Aortic Valve Implantation (TAVI)- Recent Developments 131
6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 131
6.2 Nov 18, 2019: MyVal transcatheter heart valve reports positive trial results 133
6.3 Nov 07, 2019: Edwards Lifesciences gets approval for SAPIEN 3 TAVI valve in Europe 134
6.4 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 135
6.5 Oct 23, 2019: Edwards Lifesciences reports third quarter results 137
7 Appendix 194
7.1 Methodology 194
7.2 About GlobalData 197
7.3 Contact Us 197
7.4 Disclaimer 197

List of Tables
Table 1: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development
Table 2: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Territory
Table 3: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Regulatory Path
Table 4: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Estimated Approval Date
Table 5: Transcatheter Aortic Valve Implantation (TAVI) - Ongoing Clinical Trials
Table 6: Transcatheter Aortic Valve Implantation (TAVI) Companies - Pipeline Products by Stage of Development
Table 7: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development
Table 8: Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Transcatheter Aortic Valve Replacement Device - Product Status
Table 10: Transcatheter Aortic Valve Replacement Device - Product Description
Table 11: Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 12: pTAo-TAVR - Product Status
Table 13: pTAo-TAVR - Product Description
Table 14: AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 15: AorTx Valve - Product Status
Table 16: AorTx Valve - Product Description
Table 17: Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Trilogy Aortic Valve System - Product Status
Table 19: Trilogy Aortic Valve System - Product Description
Table 20: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Gen 4 Lotus Valve System - Product Status
Table 22: Gen 4 Lotus Valve System - Product Description
Table 23: Lotus Edge Sheath 15F - Product Status
Table 24: Lotus Edge Sheath 15F - Product Description
Table 25: LOTUS Edge Valve Expanded Sizes - Product Status
Table 26: LOTUS Edge Valve Expanded Sizes - Product Description
Table 27: Lotus Edge Valve System - Product Status
Table 28: Lotus Edge Valve System - Product Description
Table 29: LOTUS Mantra - Product Status
Table 30: LOTUS Mantra - Product Description
Table 31: Lotus Valve System - 21 mm - Product Status
Table 32: Lotus Valve System - 21 mm - Product Description
Table 33: Lotus Valve System - 23 mm - Product Status
Table 34: Lotus Valve System - 23 mm - Product Description
Table 35: Lotus Valve System - 25 mm - Product Status
Table 36: Lotus Valve System - 25 mm - Product Description
Table 37: Lotus Valve System - 27 mm - Product Status
Table 38: Lotus Valve System - 27 mm - Product Description
Table 39: Lotus Valve System - 29 mm - Product Status
Table 40: Lotus Valve System - 29 mm - Product Description
Table 41: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 42: Lotus Valve System - 23 mm - Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage
Table 43: Lotus Valve System - 23 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 44: Lotus Valve System - 23 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
Table 45: Lotus Valve System - 23 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in China: REPRISE China
Table 46: Lotus Valve System - 23 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
Table 47: Lotus Valve System - 23 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Randomized Clinical Evaluation: REPRISE III
Table 48: Lotus Valve System - 23 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
Table 49: Lotus Valve System - 27 mm - Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage
Table 50: Lotus Valve System - 27 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 51: Lotus Valve System - 27 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
Table 52: Lotus Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in China: REPRISE China
Table 53: Lotus Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
Table 54: Lotus Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Randomized Clinical Evaluation: REPRISE III
Table 55: Lotus Valve System - 27 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
Table 56: Lotus Valve System - 25 mm - Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage
Table 57: Lotus Valve System - 25 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 58: Lotus Valve System - 25 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
Table 59: Lotus Valve System - 25 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in China: REPRISE China
Table 60: Lotus Valve System - 25 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
Table 61: Lotus Valve System - 25 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Randomized Clinical Evaluation: REPRISE III
Table 62: Lotus Valve System - 25 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
Table 63: Lotus Valve System - 21 mm - Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage

List of Figures
Figure 1: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Stage of Development
Figure 2: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Territory
Figure 3: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Regulatory Path
Figure 4: Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products by Estimated Approval Date
Figure 5: Transcatheter Aortic Valve Implantation (TAVI) - Ongoing Clinical Trials

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[経カテーテル大動脈弁留置術(TAVI):医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆